Functional redundancy of TGF-beta family type i receptors and receptor-smads in mediating anti-müllerian hormone-induced müllerian duct regression in the mouse

Biology of Reproduction

Volumn 78, Issue 6, 2008, Pages 994-1001

  Orvis, G D ^a,b   Jamin, S P ^b,c   Kwan, K M ^b,d   Mishina, Y ^e   Kaartinen, V M ^f   Huang, S ^g   Roberts, A B ^h   Umans, L ⁱ   Huylebroeck, D ⁱ   Zwijsen, A ⁱ   Wang, D ^j   Martin, J F ^a,j   Behringer, R R ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c INSERM   (France)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^e NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

^h NATIONAL CANCER INSTITUTE   (United States)

ⁱ UNIVERSITY OF LEUVEN   (Belgium)

^j TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

more..

Author keywords

AMH; AMHR2; Female reproductive tract; Male reproductive tract; M llerian ducts; Signal transduction; Wolffian duct

Indexed keywords

ACTIVIN RECEPTOR 1; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; MUELLERIAN INHIBITING FACTOR; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYONIC STRUCTURES; FEMALE; GENE LOSS; GENETICS; HORMONE ACTION; IMMUNOHISTOCHEMISTRY; MALE; MALE INFERTILITY; MESENCHYME; MOUSE; MUELLERIAN DUCT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION;

ACTIVIN RECEPTORS, TYPE I; ANIMALS; ANTI-MULLERIAN HORMONE; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; FEMALE; INFERTILITY, MALE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, MUTANT STRAINS; MODELS, BIOLOGICAL; MULLERIAN DUCTS; PREGNANCY; SIGNAL TRANSDUCTION; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN;

AMNIOTA; MAMMALIA; WOLFFIA;

EID: 44349154797     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.107.066605     Document Type: Article

References (51)

1. Jacob M, Christ B, Jacob HJ, Poelmann RE. The role of fibronectin and laminin in development and migration of the avian Wolffian duct with reference to somitogenesis. Anat Embryol (Berl) 1991; 183:385-395.
2. Obara-Ishihara T, Kuhlman J, Niswander L, Herzlinger D. The surface ectoderm is essential for nephric duct formation in intermediate mesoderm. Development 1999; 126:1103-1108.
3. Kobayashi A, Shawlot W, Kania A, Behringer RR. Requirement of Lim1 for female reproductive tract development. Development 2004; 131:539-549.
4. Orvis GD, Behringer RR. Cellular mechanisms of Mullerian duct formation in the mouse. Dev Biol 2007; 306:493-504.
5. Gruenwald P. The relation of the growing Müllerian duct to the Wolffian duct and its importance for the genesis of malformations. Anat Rec 1941; 81:1-19.
6. Jacob M, Konrad K, Jacob HJ. Early development of the mullerian duct in avian embryos with reference to the human. An ultrastructural and immunohistochemical study. Cells Tissues Organs 1999; 164:63-81.
7. Vainio S, Heikkila M, Kispert A, Chin N, McMahon AP. Female development in mammals is regulated by Wnt-4 signalling. Nature 1999; 397:405-409.
8. Guioli S, Sekido R, Lovell-Badge R. The origin of the Mullerian duct in chick and mouse. Dev Biol 2007; 302:389-398.
9. Carroll TJ, Park JS, Hayashi S, Majumdar A, McMahon AP. Wnt9b plays a central role in the regulation of mesenchymal to epithelial transitions underlying organogenesis of the mammalian urogenital system. Dev Cell 2005; 9:283-292.
10. Drews U. Direct and mediated effects of testosterone: analysis of sex reversed mosaic mice heterozygous for testicular feminization. Cytogenet Cell Genet 1998; 80:68-74.
11. Josso N, Lamarre I, Picard JY, Berta P, Davies N, Morichon N, Peschanski M, Jeny R. Anti-mullerian hormone in early human development. Early Hum Dev 1993; 33:91-99.
12. Jost A. Problems of fetal endocrinology. The gonadal and hypophyseal hormones. Recent Prog Horm Res. 1953; 8:379-418.
13. Behringer RR, Finegold MJ, Cate RL. Mullerian-inhibiting substance function during mammalian sexual development. Cell 1994; 79:415-425.
14. Klattig J, Sierig R, Kruspe D, Besenbeck B, Englert C. Wilms' tumor protein Wt1 is an activator of the anti-Mullerian hormnewyone receptor gene Amhr2. Mol Cell Biol 2007; 27:4355-4364.
15. Hossain A, Saunders GF. Synergistic cooperation between the beta-catenin signaling pathway and steroidogenic factor 1 in the activation of the Mullerian inhibiting substance type II receptor. J Biol Chem 2003; 278:26511-26516.
16. Parr BA, McMahon AP. Sexually dimorphic development of the mammalian reproductive tract requires Wnt-7a. Nature 1998; 395:707-710.
17. Zhan Y, Fujino A, MacLaughlin DT, Manganaro TF, Szotek PP, Arango NA, Teixeira J, Donahoe PK. Mullerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Mullerian duct regression. Development 2006; 133:2359-2369.
18. Allard S, Adin P, Gouedard L, di Clemente N, Josso N, Orgebin-Crist MC, Picard JY, Xavier F. Molecular mechanisms of hormone-mediated Mullerian duct regression: involvement of beta-catenin. Development 2000; 127:3349-3360.
19. Xavier F, Allard S. Anti-Mullerian hormone, beta-catenin and Mullerian duct regression. Mol Cell Endocrinol 2003; 211:115-121.
20. Austin HB. DiI analysis of cell migration during mullerian duct regression. Dev Biol 1995; 169:29-36.
21. Mishina Y, Whitworth DJ, Racine C, Behringer RR. High specificity of Mullerian-inhibiting substance signaling in vivo. Endocrinology 1999; 140:2084-2088.
22. Picard JY, Belville C. Genetics and molecular pathology of anti-Mullerian hormone and its receptor. J Soc Biol 2002; 196:217-221.
23. Mishina Y, Rey R, Finegold MJ, Matzuk MM, Josso N, Cate RL, Behringer RR. Genetic analysis of the Mullerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation. Genes Dev 1996; 10:2577-2587.
24. Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003; 113:685-700.
25. He W, Dorn DC, Erdjument-Bromage H, Tempst P, Moore MA, Massague J. Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. Cell 2006; 125:929-941.
26. Gouedard L, Chen YG, Thevenet L, Racine C, Borie S, Lamarre I, Josso N, Massague J, di Clemente N. Engagement of bone morphogenetic protein type IB receptor and Smad1 signaling by anti-Mullerian hormone and its type II receptor. J Biol Chem 2000; 275:27973-27978.
27. Clarke TR, Hoshiya Y, Yi SE, Liu X, Lyons KM, Donahoe PK. Mullerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression. Mol Endocrinol 2001; 15:946-959.
28. Visser JA, Olaso R, Verhoef-Post M, Kramer P, Themmen AP, Ingraham HA. The serine/threonine transmembrane receptor ALK2 mediates Mullerian inhibiting substance signaling. Mol Endocrinol 2001; 15:936-945.
29. Jamin SP, Arango NA, Mishina Y, Hanks MC, Behringer RR. Requirement of Bmpr1a for Mullerian duct regression during male sexual development. Nat Genet 2002; 32:408-410.
30. Jamin SP, Arango NA, Mishina Y, Hanks MC, Behringer RR. Genetic studies of the AMH/MIS signaling pathway for Mullerian duct regression. Mol Cell Endocrinol 2003; 211:15-19.
31. Belville C, Jamin SP, Picard JY, Josso N, di Clemente N. Role of type I receptors for anti-Mullerian hormone in the SMAT-1 Sertoli cell line. Oncogene 2005; 24:4984-4992.
32. Visser JA. AMH signaling: from receptor to target gene. Mol Cell Endocrinol 2003; 211:65-73.
33. Chang H, Huylebroeck D, Verschueren K, Guo Q, Matzuk MM, Zwijsen A. Smad5 knockout mice die at mid-gestation due to multiple embryonic and extraembryonic defects. Development 1999; 126:1631-1642.
34. Lechleider RJ, Ryan JL, Garrett L, Eng C, Deng C, Wynshaw-Boris A, Roberts AB. Targeted mutagenesis of Smad1 reveals an essential role in chorioallantoic fusion. Dev Biol 2001; 240:157-167.
35. Mishina Y, Crombie R, Bradley A, Behringer RR. Multiple roles for activin-like kinase-2 signaling during mouse embryogenesis. Dev Biol 1999; 213:314-326.
36. Mishina Y, Suzuki A, Ueno N, Behringer RR. Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis. Genes Dev 1995; 9:3027-3037.
37. Dudas M, Sridurongrit S, Nagy A, Okazaki K, Kaartinen V. Craniofacial defects in mice lacking BMP type I receptor Alk2 in neural crest cells. Mech Dev 2004; 121:173-182.
38. Mishina Y, Hanks MC, Miura S, Tallquist MD, Behringer RR. Generation of Bmpr/Alk3 conditional knockout mice. Genesis 2002; 32:69-72.
39. Huang S, Tang B, Usoskin D, Lechleider RJ, Jamin SP, Li C, Anzano MA, Ebendal T, Deng C, Roberts AB. Conditional knockout of the Smad1 gene. Genesis 2001; 32:76-79.
40. Umans L, Vermeire L, Francis A, Chang H, Huylebroeck D, Zwijsen A. Generation of a floxed allele of Smad5 for cre-mediated conditional knockout in the mouse. Genesis 2003; 37:5-11.
41. Gao F, Maiti S, Alam N, Zhang Z, Deng JM, Behringer RR, Lecureuil C, Guillou F, Huff V. The Wilms tumor gene, Wt1, is required for Sox9 expression and maintenance of tubular architecture in the developing testis. Proc Natl Acad Sci U S A 2006; 103:11987-11992.
42. Pangas SA, Li X, Umans L, Zwijsen A, Huylebroeck D, Gutierrez CC, Wang D, Martin JF, Jamin SP, Behringer RR, Robertson EJ, Matzuk MM. Conditional deletion of Smad1 and Smad5 in somatic cells of male and female gonads leads to metastatic tumor development in mice. Mol. Cell. Biol 2008; 8:248-257.
43. Kluver N, Pfennig F, Pala I, Storch K, Schlieder M, Froschauer A, Gutzeit HO, Schartl M. Differential expression of anti-Mullerian hormone (amh) and anti-Mullerian hormone receptor type II (amhrII) in the teleost medaka. Dev Dyn 2007; 236:271-281.
44. Morinaga C, Saito D, Nakamura S, Sasaki T, Asakawa S, Shimizu N, Mitani H, Furutani-Seiki M, Tanaka M, Kondoh H. The hotei mutation of medaka in the anti-Mullerian hormone receptor causes the dysregulation of germ cell and sexual development. Proc Natl Acad Sci U S A 2007; 104:9691-9696.
45. von Hofsten J, Larsson A, Olsson PE. Novel steroidogenic factor-1 homolog (ff1d) is coexpressed with anti-Mullerian hormone (AMH) in zebrafish. Dev Dyn 2005; 233:595-604.
46. Visser JA, de Jong FH, Laven JSE, Themmen AP. Anti-Mullerian hormone: a new marker for ovarian function. Reproduction 2006; 131:1-9.
47. Dyche WJ. A comparative study of the differentiation and involution of the Mullerian duct and Wolffian duct in the male and female fetal mouse. J Morphol 1979; 162:175-209.
48. Newbold RR, Pentecost BT, Yamashita S, Lum K, Miller JV, Nelson P, Blair J, Kong H, Teng C, McLachlan JA. Female gene expression in the seminal vesicle of mice after prenatal exposure to diethylstilbestrol. Endocrinology 1989; 124:2568-2576.
49. Hayashi A, Donahoe PK, Budzik GP, Trelstad RL. Periductal and matrix glycosaminoglycans in rat Mullerian duct development and regression. Dev Biol 1982; 92:16-26.
50. Ikawa H, Trelstad RL, Hutson JM, Manganaro TF, Donahoe PK. Changing patterns of fibronectin, laminin, type IV collagen, and a basement membrane proteoglycan during rat Mullerian duct regression. Dev Biol 1984; 102:260-263.
51. Trelstad RL, Hayashi A, Hayashi K, Donahoe PK. The epithelialmesesnchymal interface of the male rat Mullerian duct: loss of basement membrane integrity and ductal regression. Dev Biol 1982; 92:27-40.